The use of folic acid supplementation in psoriasis patients receiving methotrexate: A survey in the United Kingdom

Clinical and Experimental Dermatology

Volumn 25, Issue 4, 2000, Pages 265-268

  Kirby, B ^a,b   Lyon, C C ^a   Griffiths, C E M ^a   Chalmers, R J G ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b HOPE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; METHOTREXATE;

ARTICLE; DRUG EFFICACY; DRUG USE; HUMAN; MEAN CORPUSCULAR VOLUME; NAUSEA; PRIORITY JOURNAL; PSORIASIS; QUESTIONNAIRE; UNITED KINGDOM; VITAMIN SUPPLEMENTATION;

DERMATOLOGIC AGENTS; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; ERYTHROCYTE INDICES; FOLIC ACID; HUMANS; METHOTREXATE; NAUSEA; PHYSICIAN'S PRACTICE PATTERNS; PSORIASIS;

EID: 0033844453     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2230.2000.00638.x     Document Type: Article

References (10)

1. Treatment of gastrointestinal symptoms associated with methotrexate therapy for psoriasis
2. Folic acid and cyanocobalamin levels in serum and erythrocytes during low dose methotrexate therapy of rheumatoid arthritis and psoriatic arthritis patients
3. Methotrexate for psoriasis
4. Folinic acid rescue used routinely in psoriatic patients with known methotrexate sensitivity
5. The efficacy of folic acid and folinic acid in reducing methotrexate gastrointestinal toxicity in rheumatoid arthritis. A meta-analysis of randomized controlled trials
6. The effects of daily intake of folic acid on the efficacy of methotrexate therapy in children with uvenile rheumatoid arthritis. A controlled study
7. Elevation of serum hepatic aminotransferases during treatment of rheumatoid arthritis with low-dose methotrexate. Risk factors and response to folic acid
8. Efficacy of folinic acid in reducing methotrexate toxicity in juvenile idiopathic arthritis
9. The pharmacology of methotrexate
10. Folic acid supplementation during methotrexate therapy: It makes sense